Literature DB >> 17396172

Postprostatectomy risk stratification based on detection of occult lymph node metastasis.

Danil V Makarov1, Alan W Partin.   

Abstract

Year:  2007        PMID： 17396172      PMCID： PMC2373671     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  4 in total

1.  Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.

Authors:  Anna C Ferrari; Nelson N Stone; Ralf Kurek; Elizabeth Mulligan; Roy McGregor; Richard Stock; Pamela Unger; Ulf Tunn; Amir Kaisary; Michael Droller; Simon Hall; Heiner Renneberg; Kenneth J Livak; Robert E Gallagher; John Mandeli
Journal:  J Clin Oncol       Date:  2006-07-01       Impact factor: 44.544

2.  Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.

Authors:  Vincenzo Pagliarulo; Debra Hawes; Frank H Brands; Susan Groshen; Jie Cai; John P Stein; Gary Lieskovsky; Donald G Skinner; Richard J Cote
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

3.  Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Authors:  Misop Han; Alan W Partin; Marianna Zahurak; Steven Piantadosi; Johnathan I Epstein; Patrick C Walsh
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

4.  Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer.

Authors:  Masood A Khan; Alan W Partin; Leslie A Mangold; Jonathan I Epstein; Patrick C Walsh
Journal:  Urology       Date:  2003-11       Impact factor: 2.649
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.